Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Biomarker Study for the Prognosis of Patients With Hepatocellular Carcinoma and Esophageal Cancer Undergoing Radiotherapy Using Multiplex Proximity Ligation Assay

NCT01957241 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01957241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Biomarker Study for the Prognosis of Patients With Hepatocellular Carcinoma and Esophageal Cancer Undergoing Radiotherapy Using Multiplex Proximity Ligation Assay
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2011
Completion date
December 31, 2014
Enrollment
164 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, hepatocellular carcinoma